2021
DOI: 10.1177/17085381211026491
|View full text |Cite
|
Sign up to set email alerts
|

Primary angiosarcoma of aorta: A systematic review

Abstract: Purpose: To elucidate the epidemiology, anatomical, presentation, classification, pathology, investigative modalities, management and prognosis of primary angiosarcoma of the aorta. Material and Methods: A systematic review of literature from the database inception to January 2021 in PubMed and Embase, CINAHL and Cochrane Library in accordance to PRISMA was conducted. Retrieval and extraction was performed by two independent reviewers. The hierarchy of the evidence was assessed through the National Institute f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 81 publications
0
3
0
Order By: Relevance
“…Primary aortic neoplasms are uncommon [ [1] , [2] , [3] ], with the abdominal aorta as the predominant location, accounting for 40 % of the cases [ 5 ]. In this case, the diagnosis of an enlarged sinus of Valsalva aneurysm was confirmed by postsurgical pathological examination.…”
Section: Discussionmentioning
confidence: 99%
“…Primary aortic neoplasms are uncommon [ [1] , [2] , [3] ], with the abdominal aorta as the predominant location, accounting for 40 % of the cases [ 5 ]. In this case, the diagnosis of an enlarged sinus of Valsalva aneurysm was confirmed by postsurgical pathological examination.…”
Section: Discussionmentioning
confidence: 99%
“…The prognosis of angiosarcoma is poor. In the recently published systematic review of Kordzadeh et al 123 cases with primary angiosarcoma were investigated with overall median survival of 210 days or 7 months [2]. Radical surgical resection with negative margins (R0) offers the best prognosis for localized non-metastatic angiosarcoma.…”
Section: Discussionmentioning
confidence: 99%
“…Adjuvant chemotherapy with doxorubicin-containing agents demonstrated a significantly lower disease relapse and resulted in a trend for longer survival. However, survival rates of only 4% after 10 years were noted [1][2][3]. We report two cases of patients who previously underwent an endovascular aneurysm repair (EVAR), and were diagnosed with an epithelioid angiosarcoma.…”
Section: Introductionmentioning
confidence: 99%